Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Asthma · Multiple Sclerosis · TEVA

Teva Pharma

Teva Pharma GmbH

Teva Pharma clinical programs — 154 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
Status
Public
HQ
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
Employees
126
Programs
473
Drugs
447
Patents
454
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Teva Pharma projects

154 ClinicalTrials.gov programs sponsored by Teva Pharma.

Teva Pharma has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

154 programs

Clinical programs

Page 2 of 4

  1. Desmopressin Acetate 0.2 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  2. Desogestrel/ethinyl estradiol and ethinyl estradiol

    Teva Pharma GmbH

    Follicle Development

    phase 1 small molecule completed

    1 trial

  3. Dexmethylphenidate Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  4. Divalproex Sodium

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials

  5. Donepezil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  6. Donepezil Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  7. Doxycycline Monohydrate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  8. Drospirenone/Ethinyl Estradiol (Gianvi®)

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  9. Estradiol/Norethindrone acetate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  10. Famciclovir 500 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  11. Fexofenadine 180 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  12. Finasteride 5 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  13. Fluoxetine Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  14. Fluticasone Propionate MDPI

    Teva Pharma GmbH

    Asthma

    phase 1 small molecule completed

    1 trial

  15. GMX1777

    Teva Pharma GmbH

    Solid Tumors and Lymphomas

    phase 1 small molecule terminated

    1 trial

  16. GX15-070MS

    Teva Pharma GmbH

    Chronic Lymphocytic Leukemia

    phase 1 small molecule completed

    1 trial

  17. Glimepiride 4 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  18. Glucophage® XR 750 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  19. Glyburide/Metformin 5 mg/500 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  20. Granisetron hydrochloride 1 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  21. Hydrocodone Bitartrate extended-release tablet

    Teva Pharma GmbH

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  22. Hydrocodone bitartrate extended-release tablet

    Teva Pharma GmbH

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  23. LBR-101 IV

    Teva Pharma GmbH

    Bioavailability and Pharmacokinetics

    phase 1 mab completed

    1 trial

  24. Lamotrigine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  25. Lamotrigine 25 mg Chewable Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  26. Lansoprazole

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    3 trials

  27. Leflunomide 20 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  28. Levetiracetam

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials

  29. Lipegfilgrastim

    Teva Pharma GmbH

    Ewing Family of Tumors, Rhabdomyosarcoma

    phase 1 small molecule completed

    1 trial

  30. Losartan

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  31. Losartan potassium/Hydrochlorothiazide

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  32. Meloxicam 15 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  33. Metronidazole

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  34. Mirtazapine 15 mg (Orally Disintegrating) Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  35. Moexipril HCl/hydrochlorothiazide 15/25 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  36. Mycophenolate Mofetil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials

  37. NP101

    Teva Pharma GmbH

    Compare Bioequivalence Patches Previously Used in the NP101-007 Study

    phase 1 small molecule completed

    1 trial

  38. Nevirapine

    Teva Pharma GmbH

    HIV-1

    phase 1 small molecule completed

    1 trial

  39. Norethindrone/Ethinyl Estradiol

    Teva Pharma GmbH

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  40. Norethindrone/Ethinyl Estradiol

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  41. Obatoclax mesylate (GX15-070MS)

    Teva Pharma GmbH

    Hematological Malignancies

    phase 1 small molecule completed

    1 trial

  42. Olanzapine Extended Release

    Teva Pharma GmbH

    Schizophrenia, Schizoaffective Disorder

    phase 1 small molecule completed

    1 trial

  43. Omacetaxine

    Teva Pharma GmbH

    Hematologic Tumors

    phase 1 small molecule completed

    1 trial

  44. Ondansetron

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  45. Oxcarbazepine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  46. PCV-LITE-I

    Teva Pharma GmbH

    Pneumococcal infection

    phase 1 other active

    1 trial

  47. PROT-CL-NP101-015.01

    Teva Pharma GmbH

    Acute Migraine

    phase 1 small molecule completed

    1 trial

  48. Pantoprazole Sodium 40 mg delayed-release tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

Frequently asked questions

How many clinical projects does Teva Pharma have?

154 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.